We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

E:NYSEENI S.p.A. Analysis

Data as of 2026-03-30 - not real-time

$56.38

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Eni’s stock is trading at $56.38, comfortably above its 20‑day SMA (51.40) and 50‑day SMA (45.97) while still below the 200‑day SMA (38.14)‑adjusted trend, indicating a strong bullish bias. The RSI of 77 places the shares in overbought territory and the MACD histogram is modestly positive, suggesting momentum may be waning as the price approaches the identified resistance of $56.48. Volume is increasing, supporting the recent rally, but the high volatility of 25.8% over the past 30 days adds a note of caution. The beta of 0.57 indicates lower systematic risk relative to the market, yet the recent price surge has pushed the stock near its 52‑week high of $56.48, limiting further upside in the near term. Support at $45.96 remains robust, offering a cushion should a correction occur.
Fundamentally, the company commands a generous dividend yield of 4.34%, yet the payout ratio exceeds 130% and free cash flow is negative, raising sustainability concerns. The DCF fair value of $71.15 implies a potential upside of roughly 26%, but a forward P/E of 13.4 contrasts sharply with a trailing P/E of 31, reflecting earnings acceleration expectations. Recent shareholder‑return announcements and inclusion among high‑dividend large‑caps provide short‑term tailwinds, while the 12.3% revenue decline and thin operating margin underscore longer‑term challenges. Eni’s debt‑to‑equity ratio of 64.8% and a max drawdown of 19.3% highlight balance‑sheet pressure that could be exacerbated by higher energy commodity volatility.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI in overbought territory
  • Price at near 52‑week high resistance
  • High dividend payout ratio

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • DCF upside potential
  • Elevated dividend yield
  • Improving forward earnings expectations

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervaluation relative to DCF
  • Strategic shift toward renewables
  • Long‑term cash flow generation potential

Key Metrics & Analysis

Financial Health

Revenue Growth-12.30%
Profit Margin3.12%
P/E Ratio31.1
ROE5.09%
ROA2.30%
Debt/Equity64.79
P/B Ratio3.4
Op. Cash Flow$13.3B
Free Cash Flow$-4832625152
Industry P/E24.2

Technical Analysis

TrendBullish
RSI77.2
Support$45.96
Resistance$56.48
MA 20$51.40
MA 50$45.97
MA 200$38.14
MACDBullish
VolumeIncreasing
Fear & Greed Index67.43

Valuation

Fair Value$71.15
Target Price$45.16
Upside/Downside-19.90%
GradeUndervalued
TypeValue
Dividend Yield4.34%

Risk Assessment

Beta0.57
Volatility25.78%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.